Pharmaceutical News

RSS

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Human Genome Sciences, Inc. will today announce its priority goals for 2012 and report on progress with the commercialization of BENLYSTA (belimumab), the first approved drug for systemic lupus in 56 years, during a presentation this afternoon by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 30th Annual JPMorgan Healthcare Conference in San Francisco.

9 Jan 2012

Merck selects Idera Pharmaceuticals' TLR agonists for evaluation, use as vaccine adjuvant candidates

Idera Pharmaceuticals, Inc. today announced that Merck, known as MSD outside the United States and Canada, has selected several novel Toll-like Receptor agonists targeted to TLR7, TLR8 or TLR9 for evaluation and use as vaccine adjuvant candidates under the companies' collaboration and license agreement.

9 Jan 2012

Pacira provides updated timing for commercial launch of EXPAREL

Pacira Pharmaceuticals, Inc. today provided updated timing for its commercial launch of EXPAREL (bupivacaine liposome injectable suspension), a non-opioid analgesic that was approved by the U.S. Food and Drug Administration (FDA) for administration into the surgical site to produce postsurgical analgesia.

9 Jan 2012

Neutra closes formulation phase for new all-natural weight-loss supplement

Neutra Corp., an emerging nutraceuticals provider, announced today that the company is close to finalizing the formula for its new all-natural weight-loss supplement.

9 Jan 2012

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

KalVista Pharmaceuticals and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease.

9 Jan 2012

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

Colby Pharmaceutical Company (CPC) today announced publication of new results showing that a single dose of JVRS-100 adjuvanted H5N1 influenza vaccine enhanced-immune responses, -dose sparing, and -cross-clade influenza virus protection.

9 Jan 2012

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces that it has signed an agreement with miRagen Therapeutics, Inc., to assess the delivery potential of Silence's proprietary DBTC delivery system with miRagen's novel microRNA-based therapeutics.

9 Jan 2012

AICAR therapy may combat heat stroke

We've all seen the story in the news before. Whether it's the death of a physically fit high school athlete at football training camp in August, or of an elderly woman gardening in the middle of the day in July, heat stroke is a serious, life-threatening condition for which there is no treatment beyond submersion in ice water or the application of ice packs to cool the body to a normal temperature.

8 Jan 2012

NCH voluntarily recalls certain over-the-counter drugs in the U.S.

Novartis Consumer Health, Inc. (NCH) announced today that it is voluntarily recalling all lots of select bottle packaging configurations of Excedrin and NoDoz products with expiry dates of December 20, 2014 or earlier as well as Bufferin and Gas-X Prevention products with expiry dates of December 20, 2013 or earlier, in the United States.

8 Jan 2012

Americans cutting costs by skipping prescription drugs

A Consumer Reports survey revealed that more Americans are ignoring their doctor’s advice and skipping prescription drugs or medical procedures to save money in 2011 than a year earlier.

8 Jan 2012

Challenges in new product planning and development process for pharmaceutical industry

The new product planning and development process is fraught with challenges, from regulatory requirements and safety concerns to cost constraints and competitive pressures. New product planning leaders looking to safeguard their new products' success in 2012 and beyond need an updated road map to help guide them through the new clinical development landscape.

7 Jan 2012

Allsup and PRIUM partner to address pharmacy regimens and costs for MSAs

PRIUM and Allsup Medicare Secondary Payer Compliance Services have joined forces to address pharmacy regimens and costs before submitting Medicare Set-Asides to the Centers for Medicare and Medicaid Services.

7 Jan 2012

Questcor reports record vial shipments of Acthar in fourth quarter 2011

In preparation for meetings starting Monday, January 9 with investors and an investor presentation scheduled for 10:00 a.m. Thursday, January 12 at the J. P. Morgan Healthcare Conference, Questcor Pharmaceuticals, Inc. today announced preliminary operating metrics for the fourth quarter 2011.

7 Jan 2012

Trail of research that led to discovery of aspirin's role in prevention of first heart attack

Charles H. Hennekens, M.D., DrPH, the first Sir Richard Doll Research Professor as well as first recipient of an endowed chair in the new Charles E. Schmidt College of Medicine at Florida Atlantic University, has published a Citation Classic in the current issue of Clinical Chemistry. Hennekens was the founding principal investigator (PI) of the landmark Physician's Health Study and was the first to demonstrate that aspirin prevents a first heart attack.

7 Jan 2012

Cannabis Science extracts benefit squamous cell carcinoma cancer and skin cancer patients

We stumbled upon this news a couple weeks back regarding Cannabis Science, Inc. reported the continuing successful progress by two patients who have been topically self-administering Cannabis Science extracts for Squamous Cell Carcinoma Cancer and Skin Cancer.

7 Jan 2012

AVMA warns against further restrictions on cephalosporin usage in food animals that are not backed by science

The American Veterinary Medical Association (AVMA) announced today that the FDA's order prohibiting certain uses of cephalosporins in food animals appears consistent with the current AVMA position on the limited prohibition on extra-label drug use, but warned against further restrictions not backed by science.

7 Jan 2012

Stimflora launches new dietary health product

An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.

7 Jan 2012

ACAAI allergist available to discuss importance of immediate access to epinephrine

This week a seven-year-old elementary school student in Chesterfield County, Virginia, died after suffering an allergic reaction at school. Allergist Dr. Stanley Fineman, president of the American College of Allergy, Asthma and Immunology, (ACAAI) is available to discuss the importance of immediate access to epinephrine, the first-line treatment for an allergic emergency or anaphylactic reaction.

7 Jan 2012

Illegal drug use may be affecting health, death rates worldwide, Lancet report says

"About 200 million people around the world use illegal drugs every year, and that may be taking a toll on health and death rates in various countries, says a report released Thursday in the Lancet," the Los Angeles Times' "Booster Shots" blog reports.

7 Jan 2012

Breckenridge submits Paragraph IV certifications for seven ANDAs

Breckenridge Pharmaceutical, Inc.announced that it has submitted Paragraph IV (PIV) certifications for seven (7) different Abbreviated New Drug Applications (ANDA) during the 2011 calendar year and intends to submit at least five (5) each year for the next several years.

7 Jan 2012

Pharmaceutical News

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Merck selects Idera Pharmaceuticals' TLR agonists for evaluation, use as vaccine adjuvant candidates

Pacira provides updated timing for commercial launch of EXPAREL

Neutra closes formulation phase for new all-natural weight-loss supplement

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

AICAR therapy may combat heat stroke

NCH voluntarily recalls certain over-the-counter drugs in the U.S.

Americans cutting costs by skipping prescription drugs

Challenges in new product planning and development process for pharmaceutical industry

Allsup and PRIUM partner to address pharmacy regimens and costs for MSAs

Questcor reports record vial shipments of Acthar in fourth quarter 2011

Trail of research that led to discovery of aspirin's role in prevention of first heart attack

Cannabis Science extracts benefit squamous cell carcinoma cancer and skin cancer patients

AVMA warns against further restrictions on cephalosporin usage in food animals that are not backed by science

Stimflora launches new dietary health product

ACAAI allergist available to discuss importance of immediate access to epinephrine

Illegal drug use may be affecting health, death rates worldwide, Lancet report says

Breckenridge submits Paragraph IV certifications for seven ANDAs

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News